EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

SRSF2 overexpression induces transcription-/replication-dependent DNA double-strand breaks and interferes with DNA repair pathways to promote lung tumor progression

Manal Khalife, Tao Jia, Pierre Caron, Amani Shreim, Aurelie Genoux, Agnese Cristini iD, Amelie Pucciarelli, Marie Leverve, Nina Lepeltier, Néstor García-Rodríguez iD, Fabien Dalonneau, Shaliny Ramachandran und 10 weitere

NAR Cancer · 02.04.2025 · 7 (2)

DOI: 10.1093/narcan/zcaf011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NAR Cancer, online erschienen am 02.04.2025. Verfasst von Manal Khalife und 21 weiteren Autor:innen. Beteiligte Einrichtung: University Grenoble Alpes, INSERM U1209, CNRS UMR5309, Team RNA Splicing, Cell Signaling and Response to Therapies, Institute for Advanced Bioscience…. Hauptthemen laut MEDLINE: Serine-Arginine Splicing Factors, Lung Neoplasms, DNA Breaks, Double-Stranded, DNA Repair. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Univ. Grenoble Alpes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SRSF2 (serine/arginine-rich splicing factor 2) is a critical regulator of pre-messenger RNA splicing, which also plays noncanonical functions in transcription initiation and elongation. Although elevated levels of SRSF2 are associated with advanced stages of lung adenocarcinoma (LUAD), the mechanisms connecting SRSF2 to lung tumor progression remain unknown. We show that SRSF2 overexpression increases global transcription and replicative stress in LUAD cells, which correlates with the production of DNA damage, notably double-strand breaks (DSBs), likely resulting from conflicts between transcription and replication. Moreover, SRSF2 regulates DNA repair pathways by promoting homologous recombination and inhibiting nonhomologous end joining. Mechanistically, SRSF2 interacts with and enhances MRE11 (meiotic recombination 11) recruitment to chromatin, while downregulating 53BP1 messenger RNA and protein levels. Both events are likely contributing to SRSF2-mediated DNA repair process rerouting. Lastly, we show that SRSF2 and MRE11 expression is commonly elevated in LUAD and predicts poor outcome of patients. Altogether, our results identify a mechanism by which SRSF2 overexpression promotes lung cancer progression through a fine control of both DSB production and repair. Finally, we show that SRSF2 knockdown impairs late repair of ionizing radiation-induced DSBs, suggesting a more global function of SRSF2 in DSB repair by homologous recombination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Serine-Arginine Splicing FactorsLung NeoplasmsDNA Breaks, Double-StrandedDNA RepairAdenocarcinoma of LungHumansDisease ProgressionMRE11 Homologue ProteinDNA ReplicationCell Line, TumorTranscription, GeneticGene Expression Regulation, NeoplasticHomologous Recombination

Substanzen

Serine-Arginine Splicing FactorsSRSF2 protein, humanMRE11 Homologue ProteinMRE11 protein, human

Autor:innen und Institutionen

  • University Grenoble Alpes, INSERM U1209, CNRS UMR5309, Team RNA Splicing, Cell Signaling and Response to Therapies, Institute for Advanced Biosciences, Grenoble F38000, France.
  • Cancer Research Center of Toulouse (CRCT), INSERM, Université de Toulouse, CNRS, Toulouse 31037, France.
  • Departamento de Genética, Facultad de Biología, Universidad de Sevilla, Sevilla 41080, Spain; Centro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER), Universidad de Sevilla/CSIC, Sevilla 41092, Spain.
  • Department of Oncology, Oxford Institute for Radiation Oncology, University of Oxford, Oxford OX3 7DQ, United Kingdom.
  • INSERM, UMR1231, Faculty of Medicine and Pharmacy, Université de Bourgogne Franche-Comté, Dijon F21000, France.
  • University Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Team Tumor Molecular Pathology and Biomarkers, Institute for Advanced Biosciences, Grenoble F38000, France.

ORCID-Profile: Agnese Cristini, Néstor García-Rodríguez, Ester M Hammond, Pablo Huertas, Sylvie Gazzeri, Olivier Sordet, Beatrice Eymin

Förderung

  • Institut National de la Santé et de la Recherche Médicale
  • Centre National de la Recherche Scientifique
  • Univ. Grenoble Alpes
  • Fondation ARC
  • Comités Départementaux Allier, Isère and Savoie de la Ligue Nationale contre le Cancer
  • Canceropole Ile de France
  • Région Auvergne-Rhône-Alpes
  • Espoir Isère Contre Le Cancer

Zitieren

APA

Khalife, M., Jia, T., Caron, P., Shreim, A., Genoux, A., Cristini, A., Pucciarelli, A., Leverve, M., Lepeltier, N., García-Rodríguez, N., Dalonneau, F., Ramachandran, S., Fernandez Martinez, L., Marcion, G., Lemaitre, N., Brambilla, E., Garrido, C., Hammond, E. M., Huertas, P., …, & Eymin, B. (2025). SRSF2 overexpression induces transcription-/replication-dependent DNA double-strand breaks and interferes with DNA repair pathways to promote lung tumor progression. NAR Cancer, 7(2). https://doi.org/10.1093/narcan/zcaf011

Vancouver

Khalife M, Jia T, Caron P, Shreim A, Genoux A, Cristini A, et al. SRSF2 overexpression induces transcription-/replication-dependent DNA double-strand breaks and interferes with DNA repair pathways to promote lung tumor progression. NAR Cancer. 2025;7(2). doi:10.1093/narcan/zcaf011

BibTeX
@article{Khalife2025,
  author = {Khalife, Manal and Jia, Tao and Caron, Pierre and Shreim, Amani and Genoux, Aurelie and Cristini, Agnese and Pucciarelli, Amelie and Leverve, Marie and Lepeltier, Nina and García-Rodríguez, Néstor and Dalonneau, Fabien and Ramachandran, Shaliny and Fernandez Martinez, Lara and Marcion, Guillaume and Lemaitre, Nicolas and Brambilla, Elisabeth and Garrido, Carmen and Hammond, Ester M and Huertas, Pablo and Gazzeri, Sylvie and Sordet, Olivier and Eymin, Beatrice},
  title = {SRSF2 overexpression induces transcription-/replication-dependent DNA double-strand breaks and interferes with DNA repair pathways to promote lung tumor progression},
  journal = {NAR Cancer},
  year = {2025},
  volume = {7},
  number = {2},
  doi = {10.1093/narcan/zcaf011}
}
Kostenlos starten →